Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study

摘要

Perioperative hyperglycemia is associated with poor outcomes yet evidence to guide intraoperative goals and treatment modalities during non-cardiac surgery are lacking. End-stage liver disease is associated with altered glucose homeostasis; patients undergoing liver transplantation display huge fluctuations in blood glucose (BG) and represent a population of great interest. Here, we conduct a randomized trial to compare the effects of strict versus conventional glycemic control during orthotopic liver transplant (OLT). Following approval by the Institutional Review Board of the University of Michigan Medical School and informed consent, 100 adult patients undergoing OLT were recruited. Patients were randomized to either strict (target BG 80–120?mg/dL) or conventional (target BG 180–200?mg/dL) BG control with block randomization for diabetic and nondiabetic patients. The primary outcomes measured were 1-year patient and graft survival assessed on an intention to treat basis. Graft survival is defined as death or needing re-transplant (www.unos.org). Three and 5-year patient and graft survival, infectious and biliary complications were measured as secondary outcomes. Data were examined using univariate methods and Kaplan-Meir survival analysis. A sensitivity analysis was performed to compare patients with a mean BG of ≤120?mg/dL and those ?120?mg/dL regardless of treatment group. There was no statistically significant difference in patient survival between conventional and strict control respectively;1?year, 88% vs 88% (p-0.99), 3?years, 86% vs 84% (p- 0.77), 5?years, 82% vs 78. % (p-0.36). Graft survival was not different between conventional and strict control groups at 1?year, 88% vs 84% (p-0.56), 3?years 82% vs 76% (p-0.46), 5?years 78% vs 70% (p-0.362). There was no difference in patient or graft survival between intraoperative strict and conventional glycemic control during OLT. Clinical trial number and registry: www.clinicaltrials.gov NCT00780026. This trial was retrospectively registered on 10/22/2008.